{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:20:25Z","timestamp":1771636825832,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.critrevonc.2025.104631","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:10:56Z","timestamp":1737763856000},"page":"104631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Future directions in the evaluation and management of newly diagnosed metastatic cancer"],"prefix":"10.1016","volume":"208","author":[{"given":"Eric J.","family":"Lehrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chachrit","family":"Khunsriraksakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Trifiletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason P.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shankar","family":"Siva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Ost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karyn A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila T.","family":"Tchelebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan T.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy N.","family":"Showalter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Spratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar U.","family":"Kishan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaorav P.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremie","family":"Calais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Dess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ir\u00e8ne","family":"Buvat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas G.","family":"Zaorsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib1","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104631_bib2","article-title":"Semiquantitative 2-[18F]FDG PET\/CT-based parameters role in lymphoma","volume":"11","author":"Albano","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104631_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamaoncol.2020.7857","article-title":"Association of bone metastatic burden with survival benefit from prostate radiotherapy in patients with newly diagnosed metastatic prostate cancer: a secondary analysis of a randomized clinical trial","volume":"7","author":"Ali","year":"2021","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104631_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.annonc.2019.11.010","article-title":"Prevalence and mutational determinants of high tumor mutation burden in breast cancer","volume":"31","author":"Barroso-Sousa","year":"2020","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104631_bib5","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1302\/0301-620X.103B11.BJJ-2020-2261.R1","article-title":"Development of a scoring system for survival following surgery for metastatic bone disease","volume":"103-B","author":"Baumber","year":"2021","journal-title":"Bone Jt. J."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104631_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<389::AID-CNCR17>3.0.CO;2-J","article-title":"Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma","volume":"85","author":"Billingsley","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.eururo.2019.02.003","article-title":"Prostate radiotherapy for metastatic hormone-sensitive prostate cancer: a STOPCAP systematic review and meta-analysis","volume":"76","author":"Burdett","year":"2019","journal-title":"Eur. Urol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104631_bib8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med Sci. Sports Exerc"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104631_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","article-title":"Circulating tumor DNA and liquid biopsy in oncology","volume":"1","author":"Cescon","year":"2020","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2025.104631_bib11","article-title":"The epidemiology of lung metastases","volume":"8","author":"Chen","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104631_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3322\/caac.21650","article-title":"Circulating tumor DNA in advanced solid tumors: clinical relevance and future directions","volume":"71","author":"Cheng","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"15_","key":"10.1016\/j.critrevonc.2025.104631_bib13","article-title":"NRG-BR002: A phase IIR\/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and\/or surgical ablation for newly oligometastatic breast cancer (NCT02364557)","volume":"37","author":"Chmura","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104631_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000966","article-title":"Development and validation of a prognostic score to predict survival in adult patients with solid tumors and bone marrow metastases","volume":"94","author":"Chou","year":"2015","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104631_bib15","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/sim.3130","article-title":"Latent transition analysis: inference and estimation","volume":"27","author":"Chung","year":"2008","journal-title":"Stat. Med"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104631_bib16","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/annonc\/mdz396","article-title":"Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial","volume":"30","author":"Clarke","year":"2019","journal-title":"Ann. Oncol."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104631_bib17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMra1706174","article-title":"Application of cell-free DNA analysis to cancer treatment","volume":"379","author":"Corcoran","year":"2018","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104631_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.annonc.2020.11.019","article-title":"Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET\/CT(dagger)","volume":"32","author":"Cottereau","year":"2021","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104631_bib19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.surg.2018.01.004","article-title":"Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?","volume":"163","author":"Creasy","year":"2018","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104631_bib20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"\"Platinum resistant\" ovarian cancer: what is it, who to treat and how to measure benefit?","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104631_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/annonc\/mdt537","article-title":"Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival","volume":"25","author":"de Vin","year":"2014","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104631_bib22","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/cncr.32800","article-title":"Clinical outcomes of 168 Chinese patients after local surgery for bone metastases arising from advanced renal cell carcinoma","volume":"126","author":"Dong","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104631_bib23","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/j.prro.2015.02.006","article-title":"Postoperative radiation therapy for osseous metastasis: Outcomes and predictors of local failure","volume":"5","author":"Epstein-Peterson","year":"2015","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa0900043","article-title":"Preoperative staging of lung cancer with combined PET-CT","volume":"361","author":"Fischer","year":"2009","journal-title":"N. Engl. J. Med"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104631_bib25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/2192568217697691","article-title":"Spinal instability neoplastic score (SINS): reliability among spine fellows and resident physicians in orthopedic surgery and neurosurgery","volume":"7","author":"Fox","year":"2017","journal-title":"Glob. Spine J."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104631_bib26","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/s41591-018-0134-3","article-title":"Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab","volume":"24","author":"Gandara","year":"2018","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104631_bib27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib29","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol."},{"issue":"29","key":"10.1016\/j.critrevonc.2025.104631_bib30","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.19.01019","article-title":"Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)\/SWOG 80405","volume":"37","author":"Guercio","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104631_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejso.2016.10.023","article-title":"Radical surgery of oligometastatic pancreatic cancer","volume":"43","author":"Hackert","year":"2017","journal-title":"Eur. J. Surg. Oncol.: J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104631_bib32","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.annonc.2021.06.003","article-title":"Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial","volume":"32","author":"Hamid","year":"2021","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"10231","key":"10.1016\/j.critrevonc.2025.104631_bib34","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2025.104631_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101760","article-title":"Epidemiology of liver metastases","volume":"67","author":"Horn","year":"2020","journal-title":"Cancer Epidemiol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104631_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.eururo.2019.08.006","article-title":"Abiraterone in \"high-\" and \"low-risk\" metastatic hormone-sensitive prostate cancer","volume":"76","author":"Hoyle","year":"2019","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104631_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.21.01719","article-title":"Practical management of oligometastatic non-small-cell lung cancer","volume":"40","author":"Jasper","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104631_bib38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2017.76.7293","volume":"36","author":"Kalemkerian","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104631_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clgc.2017.01.010","article-title":"Outcomes of patients with metastatic renal cell carcinoma and bone metastases in the targeted therapy era","volume":"15","author":"Kalra","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s12885-017-3435-x","article-title":"Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy","volume":"17","author":"Karageorgopoulou","year":"2017","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104631_bib41","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1634\/theoncologist.2013-0442","article-title":"Effect of M1a and M1b category in metastatic colorectal cancer","volume":"19","author":"Kennecke","year":"2014","journal-title":"oncologist"},{"issue":"20","key":"10.1016\/j.critrevonc.2025.104631_bib42","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1200\/JCO.2015.63.1960","article-title":"Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013","volume":"34","author":"King","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104631_bib43","article-title":"Pulmonary metastasectomy secondary to esophageal carcinoma: long-term survival and prognostic factors","volume":"21","author":"Kobayashi","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104631_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11121-011-0201-1","article-title":"Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment","volume":"14","author":"Lanza","year":"2013","journal-title":"Prev. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamaoncol.2020.6146","article-title":"Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis","volume":"7","author":"Lehrer","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2025.104631_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000866","article-title":"Trends in diagnosis and treatment of metastatic cancer in the United States","author":"Lehrer","year":"2021","journal-title":"Am. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104631_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PPO.0000000000000105","article-title":"Imaging tumor metabolism using positron emission tomography","volume":"21","author":"Lewis","year":"2015","journal-title":"Cancer J."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104631_bib48","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2025.104631_bib49","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.blo.0000093045.56370.dd","article-title":"Metastatic disease in long bones: A proposed scoring system for diagnosing impending pathologic fractures","author":"Mirels","year":"2003","journal-title":"1989. Clin. Orthop. Relat. Res"},{"issue":"10185","key":"10.1016\/j.critrevonc.2025.104631_bib50","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104631_bib51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrclinonc.2014.96","article-title":"The oligometastatic state - separating truth from wishful thinking","volume":"11","author":"Palma","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10162","key":"10.1016\/j.critrevonc.2025.104631_bib52","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","article-title":"Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial","volume":"392","author":"Parker","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases","volume":"113","author":"Pastorino","year":"1997","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104631_bib54","first-page":"4252","article-title":"Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets","volume":"130","author":"Paul","year":"2020","journal-title":"J. Clin. Invest"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104631_bib55","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/S1470-2045(19)30157-3","article-title":"Integration of radiotherapy and immunotherapy for treatment of oligometastases","volume":"20","author":"Pitroda","year":"2019","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104631_bib56","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.26312","article-title":"Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis","volume":"3","author":"Poon","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104631_bib57","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104631_bib58","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104631_bib59","article-title":"Epidemiology of bone metastases","author":"Ryan","year":"2020","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104631_bib60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ijrobp.2022.06.095","article-title":"Local treatment of the primary tumor for patients with metastatic cancer (PRIME-TX): a meta-analysis","volume":"114","author":"Ryckman","year":"2022","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104631_bib61","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/annonc\/mds100","article-title":"Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model","volume":"23","author":"Salah","year":"2012","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104631_bib62","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00432-014-1833-x","article-title":"Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104631_bib63","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00259-024-06929-x","article-title":"Pre-treatment [18F]FDG PET\/CT biomarkers for the prediction of antibody-drug conjugates efficacy in metastatic breast cancer","volume":"52","author":"Seban","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104631_bib64","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.prp.2016.09.007","article-title":"Clinicopathologic factors associated with de novo metastatic breast cancer","volume":"212","author":"Shen","year":"2016","journal-title":"Pathol., Res. Pract."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib65","article-title":"Epidemiology of synchronous brain metastases","volume":"2","author":"Singh","year":"2020","journal-title":"Neurooncol Adv."},{"key":"10.1016\/j.critrevonc.2025.104631_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2022.05.034","article-title":"Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases","author":"Siva","year":"2022","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"31","key":"10.1016\/j.critrevonc.2025.104631_bib67","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1200\/JCO.2014.56.2561","article-title":"Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500","volume":"32","author":"Smerage","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104631_bib68","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1309\/AJCPYO5FSV3UPEXS","article-title":"Breast cancer subtypes predispose the site of distant metastases","volume":"143","author":"Soni","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"32","key":"10.1016\/j.critrevonc.2025.104631_bib69","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.20.01255","article-title":"Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"8910","key":"10.1016\/j.critrevonc.2025.104631_bib70","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(94)92529-1","article-title":"Factors influencing the natural history of colorectal liver metastases","volume":"343","author":"Stangl","year":"1994","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104631_bib71","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2025.104631_bib72","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer","volume":"(8),","author":"Temel","year":"2010","journal-title":"N. Engl. J. Med 363"},{"key":"10.1016\/j.critrevonc.2025.104631_bib73","doi-asserted-by":"crossref","unstructured":"Temel, J.S., Greer, J.A., Muzikansky, A., , 2010. Early palliative care for patients with metastatic non-small-cell lung cancer. Randomized Controlled Trial.","DOI":"10.1056\/NEJMoa1000678"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104631_bib74","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijrobp.2017.07.029","article-title":"Development and internal validation of a clinical risk score to predict pain response after palliative radiation therapy in patients with bone metastases","volume":"99","author":"van der Velden","year":"2017","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104631_bib75","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/hed.26144","article-title":"Oligometastatic head and neck cancer: Comprehensive review","volume":"42","author":"Vengaloor Thomas","year":"2020","journal-title":"Head. Neck"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104631_bib76","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer","volume":"115","author":"Wang","year":"2023","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104631_bib77","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13014-021-01790-w","article-title":"Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites?","volume":"16","author":"Weissmann","year":"2021","journal-title":"Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104631_bib78","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/bmjspcare-2020-002487","article-title":"Exercise interventions in metastatic cancer disease: a literature review and a brief discussion on current and future perspectives","volume":"10","author":"Wilk","year":"2020","journal-title":"BMJ Support Palliat. Care"},{"key":"10.1016\/j.critrevonc.2025.104631_bib79","article-title":"Pan-cancer analysis of prognostic metastatic phenotypes","author":"Zaorsky","year":"2021","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104631_bib80","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.12659\/MSM.912071","article-title":"Real-World Study of the Incidence, Risk Factors, and Prognostic Factors Associated with Bone Metastases in Women with Uterine Cervical Cancer Using Surveillance, Epidemiology, and End Results (SEER) Data Analysis","volume":"24","author":"Zhang","year":"2018","journal-title":"Med Sci. Monit."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104631_bib81","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.1987.5.5.773","article-title":"Clinical course of breast cancer patients with liver metastases","volume":"5","author":"Zinser","year":"1987","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104631_bib82","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41591-020-0915-3","article-title":"Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring","volume":"26","author":"Zviran","year":"2020","journal-title":"Nat. Med"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:02:43Z","timestamp":1741608163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":82,"alternative-id":["S1040842825000198"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104631","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future directions in the evaluation and management of newly diagnosed metastatic cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104631"}}